Premium

Pharma Giant Johnson & Johnson Asks FDA To Approve Esketamine Nasal Spray For Treatment-Resistant Depression
Decocainized Coca Leaf Derivatives Coming To US Cannabis Market Thanks To This Partnership
Dispensaries Across New York Offer Chef-Designed Luxury Cannabis Edibles From The Bettering Company
Decocainized Coca Leaf Derivatives Coming To US Cannabis Market Thanks To This Partnership
Dispensaries Across New York Offer Chef-Designed Luxury Cannabis Edibles From The Bettering Company
Ascend Wellness To Issue $235M Of Senior Secured Notes To Prepay $215M Under Term Loan
Snoop Dogg Launches 2Pac Limited Collection Honoring Legendary Rapper Who Gave Him His First Blunt

Premium Recent News

Marijuana Banking Innovator Exits $3.1M Loan, Collects Over $200K In Accrued Interest
Safe Harbor Financial exits $3.1M loan with full repayment of principal, with accrued interest reallocated into lending capacity.
Craft Weed Company Bets On New Jersey Market, Now Owns 44% Of This State-Licensed Cultivator
Mike Tyson To Open First Branded Retail Store In Amsterdam, A City That Always Held A Special Place In His Heart
Mike Tyson's cannabis brand Tyson 2.0 will open retails shop in Amsterdam, as part of its global growth strategy.
Publicly Traded Goodness Growth Cannabis Company Changes Name
Schwazze Cannabis Co Transitions To OTC Expert Market Due To Delayed Filing
Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity
'Washingtonians Share My High Expectations' For High Quality Cannabis Says Mike Tyson As His Products Reach The Evergreen State
Verano Expands Cannabis Membership Program To Dispensaries In 3 New States, Perks Include Members-Only Products And More
High Tide To Buy 'Highly Accretive' Cannabis Store For $438K
Ketamine-Assisted Therapy: 2 Psychedelics Companies Team Up To Expand Reimbursement And Training
Craft Weed Company Grown Rogue Reorganizes Shares To Keep Its Foreign Private Issuer Status In The US
Largest Manufacturer Of Cones And Combustibles, Hara Supply, Launches Tubes For Pre-Roll Joints And Blunts
Aurora Reports 20% YoY Uptick In Global Medical Marijuana, Expects Benefits From International Cannabis Regulatory Reforms
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Thursday its financial and operational results for the fourth quarter and fiscal year 2024.The company reported a 5% year-over-year increase in revenue to CA$67.4 million ($49.1 million) in the fourth quarter. Global medical cannabis net revenue grew by 20% over the same period to CA$45.6 million. The increase in net revenue1 of $7.7 million was primarily due to higher sales to Australia and Europe in the current period following the success of newly launched innovative cultivars in these markets. 
Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder
California Weed Company Sells Santa Ana Dispensary Eliminating $44.5M In Debt
Verano To Repurchase Up To $50M Of Its Shares Trading On Cboe Canada
As Michigan Becomes Nation's Top Cannabis Seller, Baker College Teams Up With Weed Brand To Offer Internships In Detroit
Canadian Edibles Producer Indiva Restructures Its Business, Obtains Creditor Protection
Class Action Lawsuit Against Scotts Miracle-Gro: Investors Allege 'Misleading Information' And 'Artificially Inflated Prices'
Cannabis REIT IIPR Buys Florida Property For $43M With Reconstruction Reimbursement, Expands Lease With Ayr Wellness
Designer And Builder Of CEA Facilities Inks $14M Contract For Expansion Of Indoor Cannabis Cultivation Facility In Ohio
Scotts Miracle-Gro Reaffirms $1B Cash Flow Target, Reduces EBITDA Earnings Expectations, Cost-Saving On Track
Cannabis Tech Firm Launches New Payment Processing Platform For Canadian Weed Retailers